David Burgstahler

David Burgstahler is a prominent figure in the finance and healthcare sectors, currently serving as a Board Member at XIFIN, Inc. since 2020. He is also the Managing Partner and CEO of Avista Capital Partners, a private equity firm he co-founded in 2005. His extensive experience includes various leadership roles in investment banking and consulting.

Professional Background

• Avista Capital Partners: As Managing Partner and CEO, Burgstahler has been instrumental in the firm's operations since its inception. He became a co-founder in 2005 and has held several leadership positions, including President and Co-CEO.
• Previous Roles: Before Avista, he worked at DLJ Merchant Banking Partners and held positions at Andersen Consulting (now Accenture) and McDonnell Douglas (now Boeing).

Board Memberships

In addition to his role at XIFIN, Burgstahler serves on the boards of several other companies:

• Arcadia Consumer Healthcare
• Cosette Pharmaceuticals
• Inform Diagnostics
• Osmotica Pharmaceuticals
• United BioSource Corporation

His diverse board experience spans both public and private companies, highlighting his expertise in healthcare and technology sectors.

Education

Burgstahler holds a Bachelor of Science degree in Aerospace Engineering from the University of Kansas and an MBA from Harvard Business School.

Overall, David Burgstahler's extensive background in finance, coupled with his leadership roles in healthcare-related companies, positions him as a significant contributor to the strategic direction of XIFIN, Inc. and other organizations within his portfolio.